BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS




Industry
Healthcare

Segment
Pharmaceuticals

Collaborations

Gilead (Durham, NC) 





 Company News
Astellas Pharma Inc. (ALPMY) Broadens Regional Leadership And Creates New Corporate Affairs And Corporate Development Functions 2/20/2015 8:39:37 AM
Astellas Pharma Inc. (ALPMY) Launches The Newest Element In Its Global Corporate Brand Campaign On CNN's Global Broadcast Network 2/16/2015 11:39:06 AM
Astellas Pharma Inc. (ALPMY) Broadens Commitment to Clinical Trial Data Transparency 2/2/2015 11:06:37 AM
Astellas Pharma Inc. (ALPMY). Immunomic Therapeutics Forge $70 Million Vaccine Pact 1/30/2015 6:28:48 AM
Astellas Pharma Inc. (ALPMY) Announces FDA Anti-Infective Drugs Advisory Committee Recommends Approval Of CRESEMBA® (Isavuconazonium) For Treatment Of Invasive Aspergillosis And Mucormycosis 1/23/2015 7:03:11 AM
FDA Panel Backs Astellas Pharma Inc. (ALPMY)'s CRESEMBA for Invasive Fungal Infections 1/22/2015 7:36:47 AM
Astellas Pharma Inc. (ALPMY) Hires Global Executive Eric Terhaerdt To Lead Global Development Operations 1/15/2015 9:58:50 AM
SSF's Cytokinetics, Inc. (CYTK) Snags $675 Million+ Deal With Astellas Pharma Inc. (ALPMY) 12/23/2014 6:21:33 AM
Astellas Pharma Inc. (ALPMY) Release: Data Presented From Phase 2 Study Of Enzalutamide In Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer 12/15/2014 10:41:27 AM
Medivation, Inc. (MDVN) And Astellas Pharma Inc. (ALPMY) Phase 3 PREVAIL Trial Named Clinical Advance Of The Year By SCRIP 12/12/2014 11:04:46 AM
12345678910...